sAA awakening

sAA awake +30min

sAA evening

AUCG

SlopeWR

SlopeD

Controls
n=24

Heart rate

0.109
p=0.613

0.059
p=0.785

0.353
p=0.091

0.277
p=0.190

0.037
p=0.862

0.431*
p=0.035

 

BTsyst

-0.183
p=0.391

-0.178
p=0.406

-0.384
p=0.096

-0.348
p=0.096

0.060
p=0.780

-0.456*
p=0.025

 

BTdiast

-0.111
p=0.606

-0.061
p=0.777

-0.193
p=0.367

-0.252
p=0.235

0.192
p=0.369

-0.232
p=0.274

 

NT-proBNP

0.253
p=0.233

0.317
p=0.131

0.303
p=0.150

0.423*
p=0.039

-0.182
p=0.394

0.186
p=0.384

Patients
n=24

Heart rate

0.317
p=0.131

0.094
p=0.662

0.222
p=0.298

0.181
p=0.397

-0.409*
p=0.047

0.284
p=0.179

 

BTsyst

-0.353
p=0.091

-0.217
p=0.309

-0.151
p=0.482

-0.193
p=0.366

0.324
p=0.123

-0.217
p=0.309

 

BTdiast

-0.467*
p=0.021

-0.342
p=0.102

-0.301
p=0.153

-0.338
p=0.106

0.296
p=0.160

-0.251
p=0.236

 

NT-proBNP

0.249
p=0.241

0.223
p=0.294

0.138
p=0.519

0.173
p=0.419

-0.195
p=0.362

0.134
p=0.533

 

NYHA class

0.279
p=0.186

0.213
p=0.327

0.326
p=0.120

0.308
p=0.142

-0.123
p=0.568

0.303
p=0.150

* Significant at the 0.05 level
Table 4: Spearman correlation coefficients (rho) and significance level (p ,2 tailed) for the control group (N=24) and the patient group (N=24) separately.